Conduit Pharmaceuticals Inc. (CDT) — Working Capital to Net Assets Ratio
Conduit Pharmaceuticals Inc. (CDT) has a Working Capital to Net Assets ratio of 53.5% as of June 2026. Working capital of $741.05 Million (current assets of $1.39 Billion minus current liabilities of $652.79 Million) is measured against net assets of $1.38 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See CDT defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Conduit Pharmaceuticals Inc. Working Capital to Net Assets (2021–2025)
This chart shows how Conduit Pharmaceuticals Inc.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 53.5%, reflecting working capital of $741.05 Million against net assets of $1.38 Billion USD. For the complete balance sheet picture, see total assets of Conduit Pharmaceuticals Inc..
Annual Working Capital to Net Assets for Conduit Pharmaceuticals Inc. (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Conduit Pharmaceuticals Inc. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check CDT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.6% | $651.88 Million | $1.26 Billion | $1.35 Billion | $697.50 Million | ▼ -66.6 pp |
| 2024 | 118.2% | $-8.03 Million | $-6.79 Million | $2.71 Million | $10.74 Million | ▲ +978.5 pp |
| 2023 | -860.4% | $3.93 Million | $-457.00K | $5.73 Million | $1.80 Million | ▼ -895.4 pp |
| 2022 | 35.0% | $-3.53 Million | $-10.09 Million | $646.64K | $4.18 Million | ▲ +463.4 pp |
| 2021 | -428.5% | $-88.34K | $20.62K | $104.16K | $192.51K | — |